OBJECTIVES: This study sought to investigate plasma levels of glucose and free fatty acids (FFA) and their relationship with adrenergic activation and insulin resistance (IR) in patients with advanced congestive heart failure (CHF). BACKGROUND: Adrenergic activation and IR are hallmarks of advanced heart failure. The resulting changes in fuel substrate availability and their implications for exercise capacity have not been elucidated. METHODS: Subjects with CHF underwent maximal exercise testing. Plasma glucose, FFA, insulin, and norepinephrine (NE) levels were measured at rest and at peak exercise. Beta-receptor sensitivity to NE was assessed using the Chronotropic Responsiveness Index (CRI). Homeostasis Model Assessment Index >2.5 defined IR. Left ventricular ejection fraction was estimated by 2-dimensional echocardiography. RESULTS: Ninety-six subjects were enrolled. CHF subjects without IR (CHF/No-IR), but not those with IR (CHF/IR), significantly increased glucose and insulin in response to exercise. Only CHF/No-IR subjects increased FFA in response to exercise (0.14 ± 0.27 mmol/l; p = 0.027). NE increased significantly less with exercise, and CRI was lower in CHF/IR subjects compared with CHF/No-IR subjects (1.3 ± 1.4 vs. 2.5 ± 2.1; 6.4 ± 2.6 vs. 8.5 ± 3.4; p = 0.069). CRI correlated with the exercise-induced increase in FFA (r = 0.41; p < 0.005). These results stayed the same after excluding diabetic patients from the CHF/IR group. CONCLUSIONS: Circulating FFA levels increased during exercise in CHF subjects without IR, but not in those with IR or DM. Increased FFA availability during exercise may represent a catecholamine-dependent compensatory fuel shift in CHF.
OBJECTIVES: This study sought to investigate plasma levels of glucose and free fatty acids (FFA) and their relationship with adrenergic activation and insulin resistance (IR) in patients with advanced congestive heart failure (CHF). BACKGROUND: Adrenergic activation and IR are hallmarks of advanced heart failure. The resulting changes in fuel substrate availability and their implications for exercise capacity have not been elucidated. METHODS: Subjects with CHF underwent maximal exercise testing. Plasma glucose, FFA, insulin, and norepinephrine (NE) levels were measured at rest and at peak exercise. Beta-receptor sensitivity to NE was assessed using the Chronotropic Responsiveness Index (CRI). Homeostasis Model Assessment Index >2.5 defined IR. Left ventricular ejection fraction was estimated by 2-dimensional echocardiography. RESULTS: Ninety-six subjects were enrolled. CHF subjects without IR (CHF/No-IR), but not those with IR (CHF/IR), significantly increased glucose and insulin in response to exercise. Only CHF/No-IR subjects increased FFA in response to exercise (0.14 ± 0.27 mmol/l; p = 0.027). NE increased significantly less with exercise, and CRI was lower in CHF/IR subjects compared with CHF/No-IR subjects (1.3 ± 1.4 vs. 2.5 ± 2.1; 6.4 ± 2.6 vs. 8.5 ± 3.4; p = 0.069). CRI correlated with the exercise-induced increase in FFA (r = 0.41; p < 0.005). These results stayed the same after excluding diabeticpatients from the CHF/IR group. CONCLUSIONS: Circulating FFA levels increased during exercise in CHF subjects without IR, but not in those with IR or DM. Increased FFA availability during exercise may represent a catecholamine-dependent compensatory fuel shift in CHF.
Authors: W S Colucci; J P Ribeiro; M B Rocco; R J Quigg; M A Creager; J D Marsh; D F Gauthier; L H Hartley Journal: Circulation Date: 1989-08 Impact factor: 29.690
Authors: Lazaros A Nikolaidis; Anthony Sturzu; Carol Stolarski; Dariush Elahi; You-Tang Shen; Richard P Shannon Journal: Cardiovasc Res Date: 2004-02-01 Impact factor: 10.787
Authors: Jochen G Schneider; Max von Eynatten; Klaus G Parhofer; Jan E Volkmer; Stephan Schiekofer; Andreas Hamann; Peter P Nawroth; Klaus A Dugi Journal: Atherosclerosis Date: 2004-08 Impact factor: 5.162
Authors: Juan F Ascaso; Susana Pardo; José T Real; Rosario I Lorente; Antonia Priego; Rafael Carmena Journal: Diabetes Care Date: 2003-12 Impact factor: 19.112
Authors: Lisa de las Fuentes; Pilar Herrero; Linda R Peterson; Daniel P Kelly; Robert J Gropler; Víctor G Dávila-Román Journal: Hypertension Date: 2003-01 Impact factor: 10.190
Authors: Rosa M Agra-Bermejo; Rocio Gonzalez-Ferreiro; J Nicolos Lopez-Canoa; Alfonso Varela-Roman; Ines Gomez-Otero; Sonia Eiras; José R González-Juanatey Journal: J Cardiovasc Transl Res Date: 2018-10-23 Impact factor: 4.132